Загрузка...
Gefitinib in the treatment of nonsmall cell lung cancer with activating epidermal growth factor receptor mutation
Lung cancer is still the main cause of cancer-related deaths worldwide, with most patients present with advanced disease and poor long-term prognosis. The aim of lung cancer treatment is to slow down the progression of the disease, to relieve the patients from the lung cancer symptoms and whenever p...
Сохранить в:
| Опубликовано в: : | J Nat Sci Biol Med |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Medknow Publications & Media Pvt Ltd
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4934098/ https://ncbi.nlm.nih.gov/pubmed/27433059 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0976-9668.184695 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|